Isabel Foley - Mar 3, 2025 Form 4 Insider Report for CRH PUBLIC LTD CO (CRH)

Role: Group General Counsel
Signature: Cot Eversole, Attorney-in-Fact for Isabel Foley
Stock symbol: CRH
Transactions as of: Mar 3, 2025
Transactions value $: -$1,927,658
Form type: 4
Date filed: 3/5/2025, 04:30 PM
Previous filing: Jan 2, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CRH	Ordinary Shares	Award	$0	+32.5K	+89.07%	$0.00	68.9K	Mar 3, 2025	Direct	F1
transaction	CRH	Ordinary Shares	Options Exercise	$0	+3.87K	+5.61%	$0.00	72.8K	Mar 3, 2025	Direct	F2
transaction	CRH	Ordinary Shares	Tax liability	-$1.93M	-20.2K	-27.82%	$95.23	52.5K	Mar 3, 2025	Direct	F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CRH	Deferred Share Award	Options Exercise	$0	-3.54K	-32.39%	$0.00	7.39K	Mar 3, 2025	Ordinary Shares	3.54K	$0.00	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects the vesting and release of awards granted in 2022 under the 2014 Performance Share Plan Rules on March 3, 2025 (including the award of 2,717 additional Ordinary Shares as dividend equivalents), pursuant to certification of the achievement of pre-established performance goals by the Compensation Committee of the Board of Directors of the Issuer (the "Compensation Committee").
F2	Reflects the vesting and release of a 2022 time-based conditional award as defined in the 2014 Deferred Share Bonus Plan (the "DSB Plan Rules"), of which, pursuant to the determination of the Compensation Committee, a total of 3,867 shares vested on March 3, 2025, including the award of 324 additional Ordinary Shares as dividend equivalents. Subject to the determination of the Compensation Committee, the remaining awards of 4,307 shares and 3,087 shares are expected to vest in March 2026 and March 2027, respectively. In accordance with the DSB Plan Rules, dividend equivalents will apply to these awards and, to the extent awarded, will be reported at the time of vesting.
F3	Mandatory sale of sufficient Ordinary Shares to cover applicable withholding tax liabilities arising in the connection with the aforementioned awards
F4	The reported price represents the volume-weighted average price of shares sold. Sale prices for the reported transaction ranged between $92.75 and $ 98.705 inclusive of shares sold on the New York Stock Exchange. Full information regarding the number of Ordinary Shares sold at each separate price in the range will be provided to the SEC upon request.